Scleroderma Clinical Trials in Toulouse
5 recruitingToulouse, France
Showing 1–5 of 5 trials
Recruiting
Phase 2
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
SclerodermaRheumatoid Arthritis (RA)Sjogren Syndrome+6 more
Artiva Biotherapeutics, Inc.90 enrolled52 locationsNCT06991114
Recruiting
Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
Inflammatory Bowel DiseasesSclerodermaVasculitis+2 more
University Hospital, Toulouse3,000 enrolled1 locationNCT05251415
Recruiting
Phase 2Phase 3
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Scleroderma, SystemicSystemic Sclerosis Associated Interstitial Lung Disease
GlaxoSmithKline300 enrolled131 locationsNCT05878717
Recruiting
Phase 2Phase 3
Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk
SclerodermaSystemic Sclerosis
University Hospital, Bordeaux90 enrolled10 locationsNCT05098704
Recruiting
Pilot Study of Description of Cicatrisation Rates of Digital Ulcers in Systemic Scleroderma
Scleroderma, Systemic
University Hospital, Limoges78 enrolled3 locationsNCT04319120